07:30 AM EST, 12/17/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Tuesday an independent data monitoring committee has recommended a move-forward dose for a potential registration-enabling phase 2/3 trial to evaluate the company's darovasertib combined with Pfizer's ( PFE ) crizotinib in patients with a certain metastatic uveal melanoma. Chief Medical Officer Darrin Beaupre said the committee's recommendation...

JERUSALEM, Dec 17 (Reuters) - Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and Crohn's disease showed it had met primary goals. Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping it will become a blockbuster drug - or one...

Dec 17 (Reuters) - Talos Energy ( TALO ) said on Tuesday it would terminate its so-called poison pill after it reached an agreement with Mexican billionaire Carlos Slim's investment firm that it would not exceed a threshold of 25% ownership in the oil and gas firm. In October, the company had adopted the shareholders rights plan after Slim's Control...

07:32 AM EST, 12/17/2024 (MT Newswires) -- Marimaca Copper ( MARIF ) said Tuesday that it signed a binding option agreement to acquire the Madrugador project in Chile. The company said Madrugador is located near the Pampa Medina project, and the acquisition consolidated its ownership of the southern extent of the Sierra de Medina property package. Under the terms, Marimaca...